Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFI

BACKGROUND: Inflammation in the vascular wall plays an important role in the pathogenesis of atherosclerosis. Current studies have shown that increase of systemic inflammatory marker like the acute phase component C-reactive protein (CRP) are associated with an unfavorable progression of disease and...

Full description

Bibliographic Details
Main Authors: Winni Agustiani, Mansyur Arif, Ilhamjaya Patellongi
Format: Article
Language:English
Published: Secretariat of The Indonesian Biomedical Journal 2011-08-01
Series:Indonesian Biomedical Journal
Online Access:http://inabj.org/index.php/ibj/article/view/143
_version_ 1818952297832513536
author Winni Agustiani
Mansyur Arif
Ilhamjaya Patellongi
author_facet Winni Agustiani
Mansyur Arif
Ilhamjaya Patellongi
author_sort Winni Agustiani
collection DOAJ
description BACKGROUND: Inflammation in the vascular wall plays an important role in the pathogenesis of atherosclerosis. Current studies have shown that increase of systemic inflammatory marker like the acute phase component C-reactive protein (CRP) are associated with an unfavorable progression of disease and an increased risk for acute cardiovascular events. Recently, a close association of Metabolic Syndrome (MetS) with hemostatic abnormalities has been reported. Among hemostatic abnormalities, an increase in plasminogen activator inhibitor (PAI)-1, a strong inhibitor of fibrinolysis, is considered a core feature of MetS. High PAI-1 concentrations may be associated with thrombus formation, also causing cardiovascular events. Therefore, we investigated the association between markers for chronic inflammation (CRP) and the markers of fibrinolytic impairment (PAI-1, PAP, TAFI) in subjects with central obesity. METHODS: This was a cross-sectional study in 80 male Indonesian subjects, aged 30-60 years old with central obesity, conducted from January to March 2008 in Bandung. RESULTS: The study results showed that there was a difference of PAI-1 levels between MetS and Non-MetS group. There were significant correlations between hsCRP and PAI-1 (r=0.252, p=0.024), hsCRP and PAP (r=0.253, p=0.024), and also between PAI-1 and PAP (r=-0.239, p=0.033) respectively. But, no correlation found between hsCRP and TAFI. CONCLUSIONS: There was correlation between inflammation and fibrinolysis impairment on central obesity. Concentrations oh hsCRP, PAI-1 and TAFI were significantly higher in MetS. KEYWORDS: inflammation, fibrinolysis impairment, hsCRP, PAI-1, PAP, TAFI.
first_indexed 2024-12-20T09:48:09Z
format Article
id doaj.art-f1ed9225f45640e3999876e4af652b1e
institution Directory Open Access Journal
issn 2085-3297
2355-9179
language English
last_indexed 2024-12-20T09:48:09Z
publishDate 2011-08-01
publisher Secretariat of The Indonesian Biomedical Journal
record_format Article
series Indonesian Biomedical Journal
spelling doaj.art-f1ed9225f45640e3999876e4af652b1e2022-12-21T19:44:42ZengSecretariat of The Indonesian Biomedical JournalIndonesian Biomedical Journal2085-32972355-91792011-08-01321273210.18585/inabj.v3i2.143135Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFIWinni Agustiani0Mansyur Arif1Ilhamjaya Patellongi2Faculty of Medicine, Hasanuddin University Jl. Perintis Kemerdekaan Km.10, MakassarFaculty of Medicine, Hasanuddin University Jl. Perintis Kemerdekaan Km.10, MakassarFaculty of Medicine, Hasanuddin University Jl. Perintis Kemerdekaan Km.10, MakassarBACKGROUND: Inflammation in the vascular wall plays an important role in the pathogenesis of atherosclerosis. Current studies have shown that increase of systemic inflammatory marker like the acute phase component C-reactive protein (CRP) are associated with an unfavorable progression of disease and an increased risk for acute cardiovascular events. Recently, a close association of Metabolic Syndrome (MetS) with hemostatic abnormalities has been reported. Among hemostatic abnormalities, an increase in plasminogen activator inhibitor (PAI)-1, a strong inhibitor of fibrinolysis, is considered a core feature of MetS. High PAI-1 concentrations may be associated with thrombus formation, also causing cardiovascular events. Therefore, we investigated the association between markers for chronic inflammation (CRP) and the markers of fibrinolytic impairment (PAI-1, PAP, TAFI) in subjects with central obesity. METHODS: This was a cross-sectional study in 80 male Indonesian subjects, aged 30-60 years old with central obesity, conducted from January to March 2008 in Bandung. RESULTS: The study results showed that there was a difference of PAI-1 levels between MetS and Non-MetS group. There were significant correlations between hsCRP and PAI-1 (r=0.252, p=0.024), hsCRP and PAP (r=0.253, p=0.024), and also between PAI-1 and PAP (r=-0.239, p=0.033) respectively. But, no correlation found between hsCRP and TAFI. CONCLUSIONS: There was correlation between inflammation and fibrinolysis impairment on central obesity. Concentrations oh hsCRP, PAI-1 and TAFI were significantly higher in MetS. KEYWORDS: inflammation, fibrinolysis impairment, hsCRP, PAI-1, PAP, TAFI.http://inabj.org/index.php/ibj/article/view/143
spellingShingle Winni Agustiani
Mansyur Arif
Ilhamjaya Patellongi
Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFI
Indonesian Biomedical Journal
title Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFI
title_full Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFI
title_fullStr Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFI
title_full_unstemmed Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFI
title_short Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFI
title_sort correlation between inflammation and fibrinolysis impairment on central obesity a study for hscrp pai 1 pap and tafi
url http://inabj.org/index.php/ibj/article/view/143
work_keys_str_mv AT winniagustiani correlationbetweeninflammationandfibrinolysisimpairmentoncentralobesityastudyforhscrppai1papandtafi
AT mansyurarif correlationbetweeninflammationandfibrinolysisimpairmentoncentralobesityastudyforhscrppai1papandtafi
AT ilhamjayapatellongi correlationbetweeninflammationandfibrinolysisimpairmentoncentralobesityastudyforhscrppai1papandtafi